NCT00168532View on ClinicalTrials.gov

Prophylactic Antibiotics in Measles

PHASE3CompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

January 31, 1998

Primary Completion Date

October 31, 2001

Study Completion Date

October 31, 2001

Conditions
Post-Measles PneumoniaMeasles
Interventions
DRUG

Sulfamethoxazole-Trimethoprim

Trial Locations (1)

1004 Bissau Codex

Bandim Health Project, Bissau

All Listed Sponsors
collaborator

Medical Research Council Unit, The Gambia

OTHER

lead

Bandim Health Project

OTHER

NCT00168532 - Prophylactic Antibiotics in Measles | Biotech Hunter | Biotech Hunter